The mechanistic target of rapamycin complex 1 (mTORC1) has been reported to be necessary for metabotropic glutamate receptor-mediated long-term depression (mGluR-LTD). Here we found that mTORC1-deficient mice exhibit normal hippocampal mGluR-LTD and associated behaviors. Moreover, rapamycin blocks mGluR-LTD in mTORC1-deficient mice. However, both rapamycin and mGluR activation regulate mTOR complex 2 (mTORC2) activity, and mTORC2-deficient mice show impaired mGluR-LTD and associated behaviors. Thus, mTORC2 is a major regulator of mGluR-LTD.
Activation of group I metabotropic glutamate receptors (mGluRs) at hippocampal CA1 synapses induces a form of longterm depression (LTD) that depends on the synthesis of new proteins 1 . mGluR-LTD is altered in a variety of neurological disorders 1 . Thus, understanding the molecular mechanisms underlying mGluR-LTD is crucial because it could lead to the potential development of new treatments for mGluR-LTD-associated cognitive disorders 1 .
The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is a highly conserved signaling hub integrating a mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors Ping Jun Zhu and quantification (c) show reduced Raptor levels and mTORC1 activity (p-S6) in hippocampus and cortex, but not cerebellum, of Raptor fb-KO mice (p-S6-Ser 240-244 : hippocampus control n = 7, Raptor fb-KO n = 8, t 13 = 13.53, P < 0.0001; cortex control n = 6, Raptor fb-KO n = 6, t 10 = 2.69, P < 0.0244, cerebellum control n = 6, Raptor fb-KO n = 6, t 10 = 0.58, P = 0.57; Raptor: hippocampus control n = 7, Raptor fb-KO n = 7, t 12 = 6.72, P < 0.001, cortex control n = 7, Raptor fb-KO n = 7, t 12 = 5.03, P < 0.001, cerebellum control n = 6, Raptor fb-KO n = 6, t 10 = 0.58, P = 0.59). fEPSPs, field excitatory postsynaptic potentials. d,e, LTD induced either with (d) DHPG (100 μ M, 10 min; control n = 12, Raptor fb-KO mice n = 8, LTD magnitude during last 10 min: control = -43.1 ± 2.4; Raptor fb-KO mice = -37.9 ± 3.7, t 18 = 1.354, P = 0.193) or (e) paired-pulse stimulation at low frequency (PP-LFS; pairs of pulses, 50-ms interval, delivered at 1 Hz, 900 pulses; control n = 7, Raptor fb-KO mice n = 12, LTD magnitude during last 10 min: control = -25.1 ± 4.5; Raptor fb-KO mice = -32.1 ± 3.4, t 17 = 1.354, P = 0.583) is intact in Raptor fb-KO mice. f, DHPG-induced LTD in Raptor fb-KO is sensitive to rapamycin (1 μ M; vehicle n = 8; rapamycin n = 7; LTD magnitude during last 10 min: vehicle = -35.1 ± 3.8; rapamycin = -17.9 ± 5.9, Mann-Whitney rank-sum test, U = 5.0, P < 0.01).
Horizontal bars indicate periods of drug application or synaptic stimulation. Inset: superimposed traces obtained before (a) and after (b) stimulation. All data are presented as mean ± s.e.m. Statistics were based on two-sided Student's t test unless otherwise specified; ns, not significant. Images of western blots were cropped to show only representative figures. Full-length blots can be found in Supplementary Fig. 8 . variety of synaptic inputs and is a major regulator of protein synthesis rates in neurons 2, 3 . The importance of mTORC1 signaling in brain processes is underscored by its postulated function in longlasting forms of synaptic plasticity and the many neurological disorders in which mTORC1 activity is perturbed 2,3 . Indeed, mTORC1 has been reported to be necessary for hippocampal mGluR-LTD 1, 4 . However, most of the evidence supporting the role of mTORC1 in mGluR-LTD is based on its pharmacological inhibition with the drug rapamycin, but recent results have challenged these findings 5 .
To further investigate the role of mTORC1 in mGluR-LTD, we used molecular genetics and conditionally deleted Raptor (which encodes the regulatory-associated protein of mTOR, a defining component of mTORC1; Fig. 1a ) 6, 7 in the murine forebrain by crossing loxP-flanked Raptor mice with CaMKIIα -Cre mice, thus generating mTORC1-deficient mice (see Methods). As expected, in the hippocampus and cortex of Raptor forebrain knockout (Raptor fb-KO) mice, Raptor levels and mTORC1 activity-as determined by phosphorylation of its downstream target, ribosomal S6 (p-S6)-were significantly reduced compared to control littermates ( Fig. 1b,c) . Accordingly, immunohistochemistry did not detect mTORC1 activity at CA1 neurons from Raptor fb-KO mice ( Supplementary Fig. 1 ). However, in the cerebellum, where Cre is expressed only modestly, mTORC1 activity and Raptor levels remained unaltered (Fig. 1b,c) . Thus, deletion of Raptor selectively reduced mTORC1 activity in the forebrain.
To investigate the role of mTORC1 in mGluR-LTD, hippocampal slices from control and Raptor fb-KO mice were treated with the selective mGluR1-and mGluR5-agonist DHPG (R,S-dihydroxyphenylglycine; 100 μ M, 10 min), which is known to reliably induce mGluR-LTD at CA1 synapses 8 . Unexpectedly, we found that DPHG resulted in normal depression of field excitatory postsynaptic potentials at Schaffer collateral-CA1 neurons in Raptor fb-KO slices, with a magnitude and time course similar to that of control littermates ( Fig. 1d ). Accordingly, paired-pulse stimulation at low frequency elicited similar mGluR-LTDs of synaptic transmission in both control and Raptor fb-KO slices ( Fig. 1e ). It is noteworthy that basal synaptic transmission was normal in hippocampal slices from Raptor fb-KO and control littermates, as determined by analysis of paired-pulse facilitation and input-output relationships ( Supplementary Fig. 2 ). Thus, irrespective of the mGluR-LTDinducing protocol, conditional deletion of mTORC1 in CA1 neurons had no effect on mGluR-induced LTD.
Given the conflicting results regarding the effects of rapamycin on mGluR-LTD 4,5 , we treated hippocampal slices from wild-type control mice with different concentrations of rapamycin. Notably, mGluR-LTD was insensitive to treatment with low concentrations of rapamycin (20 nM and 200 nM; Supplementary Fig. 3a,b ). By contrast, a high concentration of rapamycin (1 μ M) prevented mGluR-LTD in control slices ( Supplementary Fig. 3c ), but had no effect on basal synaptic properties ( Supplementary Fig. 4 ). All concentrations of rapamycin reduced mTORC1 activity ( Supplementary Fig.  3d,e ), suggesting that the high concentration of rapamycin (1 μ M) may block mGluR-LTD in an mTORC1-independent manner. To directly test this possibility, we examined the effect of a high concentration of rapamycin (1 μ M) on mGluR-LTD in hippocampal slices from mTORC1-deficient mice. Since rapamycin is reported to be highly specific for mTORC1 9 , it was expected to have no effect on mGluR-LTD in Raptor fb-KO mice. However, as in control slices ( Supplementary Fig. 3c ), rapamycin (1 μ M) inhibited mGluR-LTD in Raptor fb-KO slices (Fig. 1f ). Hence, these data support the notion that the effects of rapamycin on mGluR-LTD at CA1 synapses are independent of mTORC1.
In addition to mTORC1, another structurally and functionally distinct mTOR-containing complex, mTORC2, has been identified more recently 6, 7 . While little is known regarding its upstream regulation and downstream effectors, mTORC2 contains Rictor (rapamycin-insensitive companion of mTOR; Fig. 2a ) as an essential component that is largely insensitive to acute rapamycin treatment 6, 7 . However, in cancer cells, prolonged rapamycin treatment 10 or higher concentrations of rapamycin 11 suppress mTORC2 activity. Could mTORC2, but not mTORC1, be the major regulator of mGluR-LTD in the mammalian brain? We began addressing this question by examining whether mGluR activation engages mTORC2 function. We found that treatment with DHPG (100 μ M, 10 min) increased the activity of mTORC2, as determined by the phosphorylation of its downstream target Akt at Ser-473, a reliable readout of mTORC2 activity 6, 7 ( Supplementary Fig. 5a,b ).
We next asked whether the high concentration of rapamycin (1 μ M) sufficient to suppress mGluR-LTD would also block mTORC2 activity in control slices. Indeed, we found that high (1 μ M), but not low (20 nM and 200 nM), concentrations of rapamycin reduced mTORC2 activity ( Supplementary Fig. 5c,d ).
To investigate whether mTORC2 is required for mGluR-LTD at CA1 synapses, we studied mTORC2-deficient mice, in which Rictor (which encodes mTORC2's defining component) was conditionally deleted in the murine forebrain postnatally (Rictor fb-KO mice) 12 .
As we have previously shown, mTORC2 activity is selectively reduced in the hippocampus from Rictor fb-KO mice (Fig. 2b,c) , and basal synaptic transmission is not altered in these mice 12 . As expected, DHPG induced a typical LTD of field excitatory postsynaptic potentials in control slices (Fig. 2d ). However, in Rictor fb-KO slices, the same stimulation protocol failed to elicit mGluR-LTD (Fig. 2d ). In agreement with these observations, synaptic induction of mGluR-LTD with paired-pulse stimulation at low frequency was also impaired in Rictor fb-KO slices ( Fig. 2e ). Moreover, a high concentration of rapamycin (1 μ M) did not further reduce mGluR-LTD in Rictor fb-KO slices (Fig. 2f ). Taken together, our results indicate that mTORC2, but not mTORC1, is required for mGluR-LTD at CA1 synapses. mGluR-LTD contributes to different types of hippocampal learning and memory processes. Specifically, spatial recognition of objects has been reported to trigger a long-lasting hippocampal LTD at Schaffer collateral CA1 synapses in freely moving animals (during training; Fig. 3a ) 13, 14 . Re-exposure to the same objects on the following day is associated with reduced exploration time and absence of LTD in vivo 13, 14 . Inhibition of mGluR receptors immediately before exposure to novel objects (training) blocks LTD and the concomitant reduction in re-exploration during re-exposure 14 , indicating that this in vivo LTD depends, at least in part, on mGluR receptors. Because mGluR-LTD is impaired in slices from mTORC2-deficient mice, we next examined whether spatial recognition is also deficient in these mice. Indeed, Rictor fb-KO mice spent more time exploring the same objects compared to control littermates (Fig. 3b) , indicating that mTORC2 is required for learning mediated by hippocampal mGluR-LTD. Accordingly, mTORC2-deficient mice were also impaired in novel object recognition (Fig. 3e ), another hippocampal LTD-inducing task 14 (Fig. 3d ). The impaired hippocampal mGluR-LTD-mediated behavior in mTORC2-deficient mice is not caused by nonspecific exploratory responses, because distance traveled and exploratory behavior were similar between control and Rictor fb-KO mice ( Supplementary Fig. 6a,b) .
Because mGluR-LTD was not altered in mTORC1-deficient mice, we predicted that mGluR-LTD-related behaviors should be normal in these mice. Consistent with this prediction, we found that both spatial recognition ( Fig. 3c ) and object recognition (Fig. 3f) were normal in Raptor fb-KO mice, indicating that hippocampal mGluR-LTD and correlated behaviors did not depend on mTORC1. Finally, chronic rapamycin treatment, inhibiting both mTORC1 and mTORC2 15 , blocked spatial and object recognition ( Supplementary Fig. 7) . Thus, rapamycin-treated mice resemble Rictor fb-KO mice but not Raptor fb-KO mice with respect to their requirement for mGluR-LTD associated behaviors. Taken together, these data indicate that mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors.
mGluR-LTD is dependent on new protein synthesis 16 . While mTORC1 is a major regulator of protein synthesis in the brain 2,3 , our results suggest that the translational program underlying mGluR-LTD at CA1 synapses is independent of mTORC1. Regulation of protein synthesis at the levels of (i) initiation, by the translation initiation factor eIF2α 17 , or (ii) elongation 18 , might better explain Fig. 3 | mTORC2, but not mTORC1 , is required for hippocampal-mediated mGluR-LTD related behavior. a, Experimental model of the spatial recognition task. After habituating in an empty box, mice are exposed to two novel objects on the following day (training), and then re-exposed to the same objects 24 h later (re-exposure). b, During re-exposure, Rictor fb-KO mice (n = 10) spent more time exploring the objects than control littermates (n = 13; Mann-Whitney rank-sum test, U = 13.0, P < 0.001). NE, novel exploration. c, Hippocampal-dependent spatial recognition is intact in Raptor fb-KO mice (n = 8), as they spend similar times as control littermates (n = 10) exploring the objects during re-exposure (Mann-Whitney rank-sum test, U = 61, P = 0.828). d, Experimental design for the object recognition task. e, Rictor fb-KO mice (n = 11) show significantly lower preference for novel objects than control littermates (n = 12; Mann-Whitney rank-sum test, U = 18, P < 0.001). f, Object recognition is intact in Raptor fb-KO mice (n = 11), as they spend similar times as control littermates (n = 12) exploring novel objects during re-exposure (two-sided Student's t test, t 21 = 0.613, P = 0.547). Box plots show the minimum, maximum, median, and 25th and 75th percentiles of the groups. Mean values are indicated by thick lines.
this protein synthesis-dependent form of synaptic plasticity. While not required for hippocampal mGluR-LTD, mTORC1 is necessary for hippocampal long-term potentiation (late-LTP), another major form of synaptic plasticity in the mammalian brain, and related behaviors 19 (but also see ref. 20 ). Thus, we propose that mTORC1 at CA1 synapses is selectively required for protein synthesis-dependent increases (late-LTP), but not decreases (LTD), in synaptic efficacy. Finally, mGluR-LTD is altered in a variety of neurological disorders, including autism spectrum disorders, intellectual disability, Alzheimer's disease, epilepsy, and drug addiction 1 . In the last few years, study of the molecular mechanisms implicated in mGluR-LTD has led to the development of 'mechanism-based treatments' for some of these disorders. Unexpectedly, our results support the notion that mTORC2, but not mTORC1, is the major mTOR complex driving mGluR-LTD in the adult mammalian brain. Thus, modulation of mTORC2 may emerge as a promising new avenue for the treatment of mGluR-LTD-related disorders.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0156-7.
Mouse husbandry. All experiments were conducted on 3-to 6-month old male and female mice on a C57Bl/6 background. Raptor loxP/loxP mice were purchased from Jackson laboratory (Stock #013188) and crossed with mice expressing Cre recombinase under the control of the α subunit of calcium/ calmodulin-dependent protein kinase II (Camk2α) promoter (Camk2α-Cre) 21, 22 , thus generating Raptor fb-KO mice. Mice were weaned at the third postnatal week and genotyped by PCR. Raptor mutant and wild-type alleles were detected by PCR assay in which primer F11117 (5′ -CTCAGTAGTGGTATGTGCTCA-3′ ) and primer R11118 (5′ -GGGTACAGTATGTCAGCACAG-3′ ) amplify a 141-basepair fragment (wild-type) and a 180-basepair fragment (exon 6 of the Raptor conditional allele). Cre expression was detected by PCR with primers CreF3 (5′ -GGCCCAGCTTTCTCATATTTG-3′ ) and CreR3 (5′ -TCAGCTACACCAGAGACG-3′ ), which amplify a 488-basepair fragment. Rictor fb-KO mice were previously described 12 . Mice were kept on a 12-h/12-h light/dark cycle (lights on at 7:00 a.m.) and had access to food and water ad libitum. Animal care and experimental procedures were approved by the institutional animal care and use committee (IACUC) at Baylor College of Medicine, according to NIH guidelines.
Slice electrophysiology. Electrophysiological recordings were performed, as previously described 12, 23 . The investigators were blind to mouse genotypes. Briefly, horizontal hippocampal slices (320 μ m thick) were cut with a vibratome (Leica VT 1000 S, Leica Microsystems, Buffalo Grove, IL) at 4 °C in artificial cerebrospinal fluid solution (ACSF; 95% O 2 and 5% CO 2 ) containing, in mM: 124 NaCl, 2.0 KCl, 1.3 MgSO 4 , 2.5 CaCl 2 , 1.2 KH 2 PO 4 , 25 NaHCO 3 , and 10 glucose (2-3 mL/min). Slices were incubated for at least 60 min before recording in an interface chamber and continuously perfused with artificial cerebrospinal fluid (ACSF) at 30 °C and a flow rate of 2-3 mL/min. The recording electrodes were placed in the stratum radiatum. Field excitatory postsynaptic potentials (fEPSPs) were recorded with ACSF-filled micropipettes and were elicited by bipolar stimulating electrodes placed in the CA1 stratum radiatum to excite Schaffer collateral and commissural fibers. The intensity of the 0.1-ms pulses was adjusted to evoke 40-50% of maximal response. A stable baseline of responses at 0.033 Hz was established for at least 30 min. mGluR-LTD was induced by bath-application of DHPG (100 µ M) for 10 min or by pairing stimuli (interstimulus interval, 50 ms) delivered at 1 Hz for 15 min (900 pulses; PP-LFS), as previously described 24 . For the experiments with rapamycin, hippocampal slices were preincubated in the recording chamber with rapamycin (20 nM, 200 nM, or 1 μ M) for 30 min before DHPG application, and rapamycin was kept throughout the recording. All data are presented as means ± s.e.m. and n refers to both the number of slices and the number of mice, as appropriate. All drugs were obtained from Tocris (Ellisville, MO).
Western blotting. The hippocampus, cortex, and cerebellum from control and Raptor fb-KO mice were isolated, homogenized in cold homogenizing buffer (200 mM HEPES, 50 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EDTA, 50 mM NaF, 2 mM Na 3 VO 4 , 25 mM β -glycerophosphate, and EDTA-free complete ULTRA tablets (Roche, Indianapolis, IN), and centrifuged at 13,000 g for 10 min. The supernatants (of 30 µ g of protein/sample) were resolved on SDS-PAGE (10%) and transferred onto nitrocellulose membranes (Pall, Port Washington, NY). Treatment with DHPG, followed by biochemical analysis, was performed as previously described 4 . Briefly, after treatments, slices were snap-frozen on dry ice, then suspended in lysis buffer and analyzed by western blotting, which was performed as we previously described 12, 19 . Antibodies against p-S6 (1:1,000, Ser 240-244 #5364), p-Akt (1:1,000, Ser 473 #9271), total S6 (1:1,000 #2217), total Akt (1:1,000 #9272), Raptor (1:1,000 #2280), and Rictor (1:1,000 #2114) were purchased from Cell Signaling and Technology Laboratories (Danvers, MA); β -actin (1:5,000 #1501) was purchased from Millipore (Temecula, CA).
Spatial and object recognition. The investigators performing and scoring the behavior were blind to genotype and treatment. Spatial and object recognition were performed as previously described 13, 14, 17 , with only slight modifications. For all behavioral experiments, we included similar numbers of male and female mice for each genotype. No differences were between males and females were found (data not shown). Mice were handled for 5-10 min and habituated ('habituation') to a black Plexiglas rectangular chamber (31 × 24 cm, height 27 cm) for 10 min under dim ambient light for 3 d. Exploration of the objects was defined as sniffing of the objects (with nose contact or head directed toward the object) within a 2-cm radius of the objects. Sitting or standing on the objects was not scored as exploration. Behavior was recorded from cameras positioned above the training chamber. Data are expressed as a percentage of re-exploration ('re-exposure') relative to the initial exploration time (during 'training').
For novel-object recognition training, two identical objects were presented to mice to explore for 5 min, after which mice were returned to the home cage. Twenty-four hours later, one object was replaced by one novel object and the mouse was again placed in the chamber 5 min. The novel object had the same height and volume as the object it replaced, but different shape and appearance. The discrimination index (DI) was computed as DI = (novel-object exploration time -familiar-object exploration time/total exploration time) × 100. To control for odor cues, the open field arena and the objects were thoroughly cleaned with ethanol, dried, and ventilated between mice.
Immunofluorescence. Mice were anesthetized by isoflurane and perfused transcardially with cold 0.9% phosphate-buffered saline (PBS), followed by 4% paraformaldehyde in PBS. Brain samples were then postfixed in 4% paraformaldehyde at 4 °C overnight and cryoprotected in 30% sucrose in BPS for 3 days. Free-floating frozen sagittal sections (25 μ m) were incubated in blocking solution (10% normal goat serum, 0.3% Triton X-100, 0.01% sodium azide in PBS) for 1 h at room temperature (23-25 °C) and then transferred into diluted primary antibodies (mouse anti-NeuN, Abcam #104224, 1:500; rabbit anti-pS6-Ser 240/244 , Cell Signaling Technology #5364, 1:300) for incubation overnight. Primary antibodies were visualized using florescence-conjugated antibodies (1:1,000, goat anti-rabbit Alexa Fluor 488, ThermoFisher Scientific, #A-11034; goat anti-mouse Alexa Fluor 594, ThermoFisher Scientific, #A-11032). Image acquisition and processing were performed as we previously described 25 
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